WCM
HAE icon

Weld Capital Management’s Haemonetics HAE Stock Holding History

Weld Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,902
Closed -$529K – 558
2020
Q2 		$529K Sell
5,902
-11,322
-66% -$1.14M 0.21% 173
2020
Q1 		$1.72M Buy
+17,224
New +$1.87M 0.88% 10
2019
Q3 		– Sell
-2,515
Closed -$303K – 856
2019
Q2 		$303K Buy
+2,515
New +$247K 0.06% 542
2019
Q1 		– Sell
-6,296
Closed -$630K – 744
2018
Q4 		$630K Buy
+6,296
New +$661K 0.14% 276

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Weld Capital Management's HAE Position: Q3 2020 in Review

Weld Capital Management sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 5,902 shares — an estimated $529K sold.

Weld Capital Management first reported a position in HAE in Q4 2018 and held it in 4 quarters. The position peaked at $1.72M in Q1 2020. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • Weld Capital Management reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
  • Weld Capital Management sold 5,902 Haemonetics shares in Q3 2020, an estimated $529K.
  • Weld Capital Management first reported a position in Haemonetics in Q4 2018 and held it in 4 quarters.
  • Weld Capital Management's Haemonetics position peaked at $1.72M in Q1 2020.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.